Thoracentesis And Paracentesis Market Size Reaches $1.6 Billion In 2026: What Is Driving Growth?

Thoracentesis And Paracentesis Market Report

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Thoracentesis And Paracentesis Market Size Forecast: How Big Could The Market Get By 2030?

The thoracentesis and paracentesis market size has experienced robust expansion in recent years. Its value is projected to increase from $1.49 billion in 2025 to $1.6 billion in 2026, showing a compound annual growth rate (CAGR) of 7.4%. The growth observed in the past can be attributed to several factors including the rising prevalence of ascites and pleural effusion, the widespread adoption of conventional thoracentesis and paracentesis procedures, improvements in hospital infrastructure, increasing awareness of minimally invasive procedures, and a growing demand for diagnostic and therapeutic procedures.

The thoracentesis and paracentesis market is projected to experience substantial expansion in the coming years. It will grow to $2.15 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. This anticipated growth over the forecast period is primarily driven by factors such as the increasing acceptance of ultrasound-guided procedures, the creation of sophisticated thoracentesis and paracentesis kits, the incorporation of digital solutions for procedural management, the proliferation of ambulatory surgical centers, and dedicated efforts towards improving patient safety and procedural effectiveness. Key developments expected during this period encompass the widespread adoption of ultrasound-guided procedures, the rise of minimally invasive techniques, the convenience of point-of-care fluid drainage, improved safety protocols for procedures, and the availability of specialized therapeutic kits tailored for specific procedures.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=96534162&type=smp&name=Thoracentesis%20And%20Paracentesis%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Thoracentesis And Paracentesis Market Growth Factors: What’s Supporting Expansion?

The increasing occurrence of chronic diseases is anticipated to drive the expansion of the thoracentesis and paracentesis market moving forward. These long-term health issues endure for extended periods, frequently advance gradually, and usually demand continuous care rather than a definitive cure. The increase in chronic disease prevalence is partly linked to sedentary habits, as extended sitting and limited physical activity elevate the risk of conditions like heart ailments and diabetes. Thoracentesis and paracentesis aid in managing chronic diseases through minimally invasive procedures that remove excess fluid from the pleural or abdominal cavities, thereby easing symptoms and enhancing patient well-being. These procedures facilitate prompt monitoring and treatment for conditions such as heart failure, liver disease, and cancers, leading to fewer complications and an improved overall disease management and quality of life. For example, in April 2025, data from the Centers for Disease Control and Prevention, a US-based government agency, showed that in 2023, around 76.4% of U.S. adults (194 million) had at least one chronic condition, with 51.4% (131 million) suffering from multiple chronic conditions. Consequently, the growing prevalence of chronic diseases is a key factor propelling the growth of the thoracentesis and paracentesis market. Increased healthcare spending is anticipated to boost the growth of the thoracentesis and paracentesis market in the future. Healthcare spending encompasses all financial outlays for medical services, products, and public health initiatives aimed at preventing, diagnosing, treating, and managing diseases, as well as preserving general health. The heightened need for healthcare expenditure stems from the growing incidence of chronic diseases, which necessitate long-term and expensive care. Thoracentesis and paracentesis contribute to lowering healthcare costs by facilitating minimally invasive fluid extraction, thereby shortening hospitalizations, reducing complication rates, and decreasing the reliance on expensive interventions. For example, in May 2024, the Office for National Statistics, a UK-based government department, reported that total healthcare expenditure rose by 5.6% in nominal terms in 2023, representing a 0.9% growth compared to 2022. Thus, the escalating healthcare spending is a key factor propelling the growth of the thoracentesis and paracentesis market.

Thoracentesis And Paracentesis Market Segment Outlook: Which Categories Are Growing Fastest?

The thoracentesis and paracentesis market covered in this report is segmented –

1) By Procedure Type: Ultrasound-Guided Procedures, Blind Or Conventional Procedures

2) By Product Type: Thoracentesis Kits, Paracentesis Kits, Other Product Types

3) By Indication: Ascites, Pleural Effusion, Empyema, Hemothorax

4) By Application: Diagnostic, Therapeutic

5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Ultrasound-Guided Procedures: Diagnostic Ultrasound Guided Procedure, Therapeutic Ultrasound Guided Procedure, Emergency Ultrasound Guided Procedure

2) By Blind Or Conventional Procedures: Diagnostic Blind Procedure, Therapeutic Blind Procedure, Emergency Blind Procedure

Thoracentesis And Paracentesis Market Industry Trends: What’s Reshaping Demand?

Major companies operating in the thoracentesis and paracentesis market are concentrating on developing advanced technological solutions, such as fluid drainage automation, to elevate procedural safety, lessen patient discomfort, boost clinical efficiency, and enable continuous monitoring for improved treatment outcomes. Fluid drainage automation refers to the deployment of devices or systems to automatically manage the removal of bodily fluids from cavities, controlling flow, pressure, and safety to enhance operational efficiency and patient comfort. For instance, in January 2024, Laborie Medical Technologies Inc., a US-based medical technology company, launched the RenovarP Centesis System. This is a fluid drainage device that builds upon an existing paracentesis pump by including an expanded indication for thoracentesis. It incorporates design improvements to its handle and nest, thereby enhancing the overall user experience for healthcare professionals. The system offers a secure, effective, and minimally invasive method for draining fluid from the abdomen (paracentesis) and chest (thoracentesis), aiming to improve patient comfort and shorten recovery times.

Thoracentesis And Paracentesis Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the thoracentesis paracentesis market are Cardinal Health Inc., Medtronic plc, Becton Dickinson Company, Boston Scientific Corporation, Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., Redax S.p.A., Avanos Medical Inc., Poly Medicure Ltd., Axiom Medical Inc., Angiplast Private Limited, Utah Medical Products Inc., Mermaid Medical A/S, PFM Medical AG, ITL Australia Pty Ltd, ATMOS MedizinTechnik GmbH & Co. KG, Vygon SA, PolyMed Medical Devices Pvt. Ltd., Sterimed Medical Devices Pvt. Ltd., Blue Neem Medical Devices Pvt. Ltd.

View The Full Thoracentesis And Paracentesis Market Report:

https://thebusinessresearchcompany.com/report/thoracentesis-and-paracentesis-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Thoracentesis And Paracentesis Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the thoracentesis and paracentesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thoracentesis and paracentesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model